Water-filtered infrared A reduces chlamydial infectivity in vitro without causing ex vivo eye damage in pig and mouse models by Rahn, Carolin
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2016
Water-filtered infrared A reduces chlamydial infectivity in vitro without
causing ex vivo eye damage in pig and mouse models
Rahn, Carolin
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-136433
Published Version
Originally published at:
Rahn, Carolin. Water-filtered infrared A reduces chlamydial infectivity in vitro without causing ex vivo
eye damage in pig and mouse models. 2016, University of Zurich, Vetsuisse Faculty.
  
Institut für Veterinärpathologie  
der Vetsuisse-Fakultät Universität Zürich 
 
 
 
Direktorin: Prof. Dr. Anja Kipar 
 
 
 
Arbeit unter wissenschaftlicher Betreuung von 
Prof. Dr. Nicole Borel 
 
 
Water-filtered infrared A reduces chlamydial infectivity in vitro 
without causing ex vivo eye damage in pig and mouse models 
 
 
 
 
 
 
Inaugural-Dissertation 
 
 
zur Erlangung der Doktorwürde der  
Vetsuisse-Fakultät Universität Zürich 
 
 
vorgelegt von 
 
 
 
Carolin Rahn 
 
 
Tierärztin 
von Hagen, Deutschland 
 
 
 
genehmigt auf Antrag von 
 
 
Prof. Dr. Nicole Borel, Referentin 
Prof. em. Dr. Jan-Olaf Gebbers, Korreferent 
 
 
2016 
 
 
  
Institut für Veterinärpathologie  
der Vetsuisse-Fakultät Universität Zürich 
 
 
 
Direktorin: Prof. Dr. Anja Kipar 
 
 
 
Arbeit unter wissenschaftlicher Betreuung von 
Prof. Dr. Nicole Borel 
 
 
Water-filtered infrared A reduces chlamydial infectivity in vitro 
without causing ex vivo eye damage in pig and mouse models 
 
 
 
 
 
 
Inaugural-Dissertation 
 
 
zur Erlangung der Doktorwürde der  
Vetsuisse-Fakultät Universität Zürich 
 
 
vorgelegt von 
 
 
 
Carolin Rahn 
 
 
Tierärztin 
von Hagen, Deutschland 
 
 
 
genehmigt auf Antrag von 
 
 
Prof. Dr. Nicole Borel, Referentin 
Prof. em. Dr. Jan-Olaf Gebbers, Korreferent 
 
 
2016 
 
 
 
 
 
 
 
 
 
 
 2 
INDEX 
 
ZUSAMMENFASSUNG       3 
SUMMARY         4 
ORIGINAL ARTICLE        5 
 ABSTRACT        6 
 INTRODUCTION       7 
 MATERIAL AND METHODS     10 
 RESULTS         18 
 DISCUSSION        28 
 ACKNOWLEDGEMENTS      33 
 REFERENCES        34 
 SUPPORTING INFORMATION     40 
CURRICULUM VITAE 
 
  
 3 
Vetsuisse-Fakultät Universität Zürich 2016 
 
Carolin Rahn 
 
Institut für Veterinärpathologie 
ivpz@vetpath.uzh.ch 
 
Wassergefilterte Infrarot A Strahlung kann Chlamydieninfektionen in vitro reduzieren ohne 
negative Effekte auf okuläre Strukturen in ex vivo Schweine- und Mausmodellen hervorzurufen 
 
Rezidivierende okuläre Infektionen mit Chlamydia trachomatis führen zum sogenannten Trachom, die 
häufigste Ursache für infektionsbedingte Erblindung. Die Anwendung von wassergefilterter Infrarot A 
Strahlung (wIRA) hat positive Effekte in Zellkulturversuchen und auf der menschlichen Haut gezeigt. 
Das Ziel dieser Studie war es, das Potential von wIRA als mögliche nicht-chemische Therapie für 
Trachompatienten zu evaluieren.  
Zu diesem Zweck wurden humane Konjunktivalepithelzellen (HCjE) mit C. trachomatis B infiziert und 
mit wIRA bestrahlt, um den Effekt von wIRA auf die Infektiösität der Chlamydien zu erfassen. 
Weiterhin wurden mögliche schädliche Effekte durch wIRA in zwei nicht-infizierten ex vivo 
Augenmodellen untersucht. 
Die Temperaturentwicklung während der Bestrahlung wurde in der Zellkultur und in ex vivo 
Schweineaugen gemessen. Zusätzlich wurde die Zellvitalität der HCjE und die Zytotoxizität in Retina-
Maus-Explantaten nach wIRA-Applikation analysiert. 
Die Studie konnte zeigen, dass die wIRA-Behandlung von infizierten HCjE vor und nach der Infektion 
ausreichend war, um die Infektiösität der Chlamydien zu verhindern und dass der Zusatz von 
sichtbarem Licht den Effekt von wIRA verstärken konnte. Die Zellvitalität wurde durch die Bestrahlung 
nicht negativ beeinflusst und es gab keine Hinweise auf wIRA-induzierte Schädigungen der Retina. 
Die physiologischen Augentemperaturen wurden nur geringgradig überschritten, weshalb 
Hypertermie-bedingte Läsionen unwahrscheinlich sind.  
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Water-filtered infrared A reduces chlamydial infectivity in vitro without causing ex vivo eye 
damage in pig and mouse models 
 
Repeated ocular infections with Chlamydia trachomatis are triggering the development of trachoma, 
the most common cause of infections blindness worldwide. Water-filtered infrared A (wIRA) has shown 
positive effects on cultured cells and human skin. Our aim was to evaluate the potential of wIRA as a 
possible non-chemical treatment for trachoma patients. We both modeled ocular chlamydial infections 
using C. trachomatis B to infect human conjunctival epithelial cells  (HCjE) and studied the effects of 
wIRA on non-infected ocular structures with two ex vivo eye models. Thereby we focused on the 
temperature development during wIRA irradiation in cell culture and perfused pig eyes to exclude 
potentially harmful side effects. Furthermore, cell viability of HCjE and cytotoxicity in mouse retina 
explants was analyzed. 
We demonstrated a significant wIRA-dependent reduction of chlamydial infectivity in HCjE cells. 
Moreover, we observed that wIRA treatment of HCjE prior to infection was sufficient to inhibit 
chlamydial infectivity and that visible light enhances the effect of wIRA. Irradiation did not reduce cell 
viability and there was no indication of retinal damage post treatment. Additionally, temperatures 
during wIRA exposure did not markedly exceed physiological eye temperatures, suggesting that 
hyperthermia-related lesions are unlikely. For clinically applications further exploration of wIRA as a 
non-chemical treatment device in an experimental animal model is essential. 
 
 
Keywords: Chlamydiaceae, vitreous body, retina, temperature, cytotoxicity 
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Abstract 
Repeated ocular infections with Chlamydia trachomatis trigger the development of trachoma, the most 
common cause of infectious blindness worldwide. Water-filtered infrared A (wIRA) has shown positive 
effects on cultured cells and human skin. Our aim was to evaluate the potential of wIRA as a possible 
non-chemical treatment for trachoma patients. We both modeled ocular chlamydial infections using C. 
trachomatis B to infect human conjunctival epithelial cells (HCjE) and studied the effects of wIRA on 
non-infected ocular structures with two ex vivo eye models. Thereby we focused on the temperature 
development during wIRA irradiation in cell culture and perfused pig eyes to exclude potentially 
harmful side effects. Furthermore, cell viability of HCjE and cytotoxicity in mouse retina explants were 
analyzed. 
We demonstrated a significant wIRA-dependent reduction of chlamydial infectivity in HCjE cells. 
Moreover, we observed that wIRA treatment of HCjE prior to infection was sufficient to inhibit 
chlamydial infectivity and that visible light enhances the effect of wIRA. Irradiation did not reduce cell 
viability and there was no indication of retinal damage post treatment. Additionally, temperatures 
during wIRA exposure did not markedly exceed physiological eye temperatures, suggesting that 
hyperthermia-related lesions are unlikely. For clinical applications further exploration of wIRA as a 
non-chemical treatment device in an experimental animal model is essential. 
Keywords: Chlamydiaceae, vitreous body, retina, temperature, cytotoxicity 
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1. Introduction  
Trachoma is a human infectious ocular disease and a major cause of preventable blindness 
worldwide, specifically in Africa, Asia, Central and South America, Australia and the Middle East. 
Approximately 229 million people are currently at risk of contracting trachoma according to the World 
Health Organization (WHO). Conjunctival infection with Chlamydia (C.) trachomatis ocular strains A, B 
or C marks the onset of trachoma and is followed by four clinical stages: i) papillary hypertrophy and 
lymphoid follicles (active trachoma) affecting an estimated 21 million people, ii) accumulation of scar 
tissue in the conjunctiva, iii) eyelid distortion and scarring of the cornea through rubbing lashes 
(trichiasis, affecting approximately 7.3 million people) and iv) corneal opacification leading to 
irreversible blindness with approximately 1.2 million people affected worldwide (1-3). 
To date, the SAFE strategy is used in an attempt to eliminate endemic blinding trachoma, and 
includes Surgery for trachomatous trichiasis, Antibiotic treatment, Facial cleanliness and 
Environmental improvement such as general community hygiene, adequate water supply and 
construction of sanitary facilities (2–4). For individuals suffering from active trachoma, antibiotic 
treatment with azithromycin or doxycycline is the most common therapy and is often applied via mass 
drug administration (MDA) in endemic regions as part of the elimination program (4). A study by West 
et al. demonstrated that even after multiple MDA treatments, one third of the patients still had eye 
infections with C. trachomatis. Although they did not find evidence for azithromycin resistance, the 
possibility could not be ruled out completely (5). Antimicrobial resistance in general has become a 
major public health concern in recent years. Pathogens have developed resistance to multiple classes 
of antibiotics, so the limitation of antibiotic use is encouraged worldwide, especially in food production 
herds (6).  
Of particular interest is the emergence of tetracycline resistance in C. suis, a growing problem in the 
pig rearing industry and probably the result of excessive tetracycline use for therapeutic purposes and 
as growth promoters in livestock since the 1950s (7–11). C. suis is primarily known to inapparently 
infect the porcine gastrointestinal tract with a prevalence of up to 90 % in fattening pigs (12). Together 
with C. trachomatis, C. suis belongs to the obligate intracellular and Gram-negative bacterial family 
Chlamydiaceae, which is characterized by a unique biphasic lifecycle consisting of infectious 
elementary bodies (EBs) and intracellular, dividing reticulate bodies (RBs) (12,13). Alarmingly, mixed 
infections with C. trachomatis and C. suis have been reported in Nepalese trachoma patients, while 
co-infection of the two closely related species generated tetracycline resistant C. trachomatis strains in 
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vitro (14,15). Taking these findings together, mixed infection with tetracycline resistant C. suis and 
ocular C. trachomatis strains may amplify the emergence of therapy-resistant trachoma strains. 
Therefore, the development of alternative, preferably non-chemical, treatment methods may aid 
achievement of the WHO goal established in 1997 to eliminate trachoma by the year 2020 (3). 
Water-filtered infrared A radiation (wIRA) with a radiation spectrum ranging from 780 to 1400 nm has 
been used successfully, either alone or in combination with visible light (VIS), to aid the healing 
process of acute and chronic wounds, improving tissue oxygen partial pressure and perfusion, as well 
as reducing pain, inflammation and the frequency of wound infection (16–19) . 
In our previous studies, we demonstrated that wIRA or wIRA/VIS treatment reduced chlamydial 
infectivity in permanent cell lines such as HeLa and Vero cells (20,21). Here, our goal was to study the 
effect of wIRA with and without visible light on an established in vitro ocular infection model to 
investigate the possibility of wIRA as a potential treatment for trachoma. We infected human 
conjunctival epithelial cells with the ocular serovar Chlamydia trachomatis B, irradiated cells and/or 
bacteria, either prior to infection or 40 hours post infection, and evaluated the potential reductive effect 
of wIRA or wIRA/VIS on chlamydial infectivity. Since the eye is a highly complex and heterogeneous 
organ with different anatomic structures such as the cornea, the vitreous body and the thermo- and 
photo-sensitive retina (22), we further investigated the effect of wIRA and wIRA/VIS irradiation on the 
non-infected eye. First, we focused on temperature inside the cornea, sclera and the vitreous body of 
isolated pigs eyes during irradiation. Pig eyes were chosen due to their similarity to human eyes in 
regards to size as well as histological and physiological features (23). Second, in order to investigate 
the effect of wIRA irradiation and temperature on the retina, we used adult and postnatal mouse retina 
explants, an established ex vivo organ model that is known to be particularly sensitive to stressors 
(24–26). Both eye models were evaluated for temperature changes upon irradiation. The retina 
explant model was further examined via ELISA, for activation of various markers of cytotoxicity. 
In summary, we demonstrated that vitreal temperature, which can affect the neighboring thermo-
sensitive retina, is increased up to 38.4 °C in pig eyes at irradiation doses used to treat infection in 
vitro. However, wIRA/VIS does not activate markers of cytotoxicity such as phosphorylated p38, Akt, 
Erk or SAPK/JNK in the highly photo- and heat-sensitive retinae of adult and postnatal mice. In 
addition, we show that both wIRA and wIRA/VIS reduce C. trachomatis in an in vitro eye infection 
model. In particular, the combined irradiation of cells and EBs prior infection has a strong inhibiting 
effect on chlamydial infectivity. Taken together, these data indicate that this study is an important early 
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step in the potential introduction of wIRA or wIRA/VIS as a new, non-chemical treatment method to aid 
the elimination of trachoma. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 10 
2. Material and Methods 
2.1 Preparation of isolated pig eyes 
Pig eyes were obtained from an abattoir and transported on ice. Post mortem time of experiments 
ranged from one to eight hours. Perfusion of eyes was modified from the method described by Wilson 
et al. (27) and Shahidullah et al. (28), (Figure 1). Briefly, the ciliary artery was cannulated with a 25G 
needle at the point where it enters the sclera. The eyes were placed in a water bath (with temperature 
adjusted for each experiment), containing Krebs’ solution [mM: NaCl, 118; KCl, 4.7; MgSO4, 1.2; 
CaCl2, 2.5; NaHCO3, 25; KH2PO4, 1.2; glucose, 11.5; ascorbate 0.05; glutathione, 1.0 (pH 7.4)]. The 
cornea was not covered by the solution. The perfusion with Krebs’ solution was performed with a 
peristaltic pump (Watson marlow 505U) with flow rate of 1.4 mL/min. To mimic physiologic conditions 
during irradiation, the cornea was washed constantly with Krebs’ solution by the same peristaltic 
pump. A digital pressure transducer (Greisinger GMH5155) was used to measure the arterial pressure 
to ensure it did not exceed 140 mmHg. Perfusion was checked before and after each experiment. 
Successful perfusion was indicated by constant flow through the vortex veins. For temperature 
measurement, sensors of a digital thermometer (Testo735, Testo AG, Lenzkirch, Germany) were 
placed in the middle of the vitreous body and on the top of the cornea.   
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Figure 1. Schematic diagram of the pig eye perfusion model. 
Pig eyes were placed in a water bath with Krebs’ solution, with the cornea not covered by the solution. 
Perfusion was performed by cannulating the ciliary artery, pumping the solution through the eyes by a 
peristaltic pump with a constant flow rate, representing arterial pressure, and draining through the 
vortex veins. The cornea was constantly washed with Krebs’ solution by the same peristaltic pump. 
The temperature during irradiation was measured in the middle of the vitreous body or on the top of 
the cornea. 
 
2.2 Irradiation of isolated pig eyes 
Pig eyes were exposed to wIRA/VIS with a final radiation spectrum ranging from 595 to 1400 nm for 
30 min using a Hydrosun 750 wIRA radiator (Hydrosun GmbH, Müllheim, Germany) with an orange 
filter (BTE 595, Hydrosun GmbH) at irradiation doses of 1000, 2100, 3700 and 5000 W/m2. In another 
set of experiments, pig eyes were additionally irradiated with wIRA alone for 30 min using a black filter 
(RG 780, Hydrosun GmbH) emitting a spectrum of 780 to 1400 nm, at 2000 W/m2, which is the 
corresponding irradiation dose of wIRA/VIS 2100 W/m2 if the BTE 595 is used.   
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2.3 Preparation, temperature exposure and irradiation of mouse retina explants 
The eyes of adult or postnatal (10 days old, P10) C57BL/6 mice were removed after decapitation; the 
retinae with the vitreous bodies were isolated by using a binocular microscope and cultured with 500 
µl medium per well [DMEM complemented with 10% FCS, 1% L-glutamine, 1% nonessential amino 
acids, 100 U/mL penicillin, and 0.1 mg/mL streptomycin] in a 24-well plate (TPP, Trasadingen, 
Switzerland) at 37 °C and 5% CO2 for 30 min as previously described (29). Subsequently, well plates 
were placed into a circulating water bath at 37 °C or 40 °C inside of an incubator (37 °C) for another 
30 min with (+wIRA) and without (Ctrl) wIRA/VIS treatment (BTE 595) at 1000 W/m2. For ELISA 
analysis, vitreous bodies were removed from the retinae before fixation by snap freezing. Retinae 
were then sonicated three times for 1 min each in cell lysis buffer (Cell Signaling Technologies, 
Cambridge, UK, #9803). ELISA assay for p-p38 (Cell Signaling Technology, #7946), pAkt (Cell 
Signaling Technology, #7252), pErk (Cell Signaling Technology, #7177) and pSAPK/JNK (Cell 
Signaling Technology, #7325) was performed according to the manufacturer’s protocol.  
 
2.4 Host cells and media 
For cell culture experiments, human conjunctival epithelial cells (HCjE), immortalized by hTERT 
transfection, which were kindly donated by Prof. Ilene Gipson (Schepens Eye Research Institute, 
Harvard Medical School, Boston) (30), were used for the infection experiments. Reinfection 
experiments were performed in HeLa cells (Homo sapiens cervix adenocarcinoma, CCL-2 ATCC). For 
cell propagation, the cell lines were incubated at 37°C and 5% CO2 in growth culture medium. HCjE 
growth medium consisted of Keratinocyte Serum-Free Medium (GIBCO, Invitrogen, Carlsbad, CA, 
USA) supplemented with 25 µg/mL bovine pituitary extract (BPE, GIBCO), 0.2 ng/mL epidermal 
growth factor (EGF), 0.4 mM calcium chloride (Sigma-Aldrich Co., St. Louis, MO, USA) and 0.2 mg/L 
gentamycin (50 mg/mL, GIBCO). Neutralization medium, composed of Dulbecco`s Modified Eagle 
Medium/Nutrient Mixture F-12 (DMEM/F12, GIBCO) with 10% fetal calf serum (FCS, BioConcept, 
Allschwil, Switzerland) was used for the thawing of cells, serial passaging and infection of HCjE, as 
previously described (30). 
HeLa growth medium consisted of Minimal Essential Medium (MEM) with Earle’s salts, 25 mM 
HEPES, without L-Glutamine (GIBCO) supplemented with 10% fetal calf serum (BioConcept), 4 mM 
GlutaMAX-I (200mM, GIBCO), 0.2 mg/mL gentamycin (50 mg/mL, GIBCO) and 1% MEM Non-
Essential Amino Acids (MEM NEAA, 100x, GIBCO). 
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For infection experiments, cells were seeded on glass coverslips (13 mm diameter, Sterilin Limited; 
Thermo Fisher Scientific, Waltham, MA, USA), which were placed in 24-well plates (Techno Plastic 
Products AG (TPP), Trasadingen, Switzerland). Prior to seeding HCjE, coverslips were coated with 50 
µg/mL Rat-Tail Collagen I (Discovery Labware, Inc., Bedford, MA, USA) diluted in 0.02 N acetic acid 
(Carl Roth, Karlsruhe, Germany). When cells reached a confluency of 80-90%, they were plated at a 
density of 1.5x105 cells/well and grown for 48 hours in 1 mL growth medium. HeLa cells were 
processed as previously described (20).  
 
2.5 Chlamydial strains 
In the present study, Chlamydia (C.) trachomatis, serotype B (strain HAR-36, VR-573 ATCC, kindly 
provided by T. Barisani-Asenbauer, Vienna, Austria) was used for all infection experiments with HCjE 
cells. The strain was propagated and stored at -80°C as previously described (20), in LLC-MK2 cells 
(CCL-7 ACCT, kindly provided by M. Donati, Bologna, Italy) as reported previously (31) . 
 
2.6 Irradiation of HCjE and temperature measurement during irradiation 
In this study, infected and non-infected cells were exposed either to wIRA alone (RG 780) or wIRA/VIS 
(BTE 595) for 30 min at 2000 W/m2 and 2100 W/m2, respectively. 
Aiming for a stable temperature during irradiation, 24-well plates were placed into a circulating water-
bath (SC100, Thermo Fisher Scientific), which served as a cooling system with an adjusted 
temperature of 37 °C. Intra-well temperature was checked every 5 min during 30 min of irradiation with 
a Voltcraft thermometer (Type 2ABAc, Philips, Kassel, Germany) as previously described (20).  
 
2.7 Determination of cell viability  
2.7.1 AlamarBlue assay 
10% AlamarBlue dye (Biozol, Eching, Germany) was added to the wells immediately after irradiating 
non-infected HCjE once or four times (0 h, 2 h, 5 h and 8 h) for 30 min with 2000 W/m2 wIRA or 2100 
W/m2 wIRA/VIS. Plates were then incubated for 3 h at 37 °C and fluorescence was determined at 560 
nm excitation and 590 nm emission wavelength (LS55 luminescence spectrometer, Perkin-Elmer) as 
previously described (32). Heat denatured cells (h.d.) served as a positive control.  
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2.7.2 Evaluating average number of cells per field 
After fixation of cell cultures in 1 mL methanol for 10 min, nuclei were stained with 4’,6-Diamidin-2’-
phenylindoldihydrochlorid (1:1000, DAPI, 1 µg/mL, Molecular Probes, Eugene, OR, USA) and 
coverslips were mounted on glass slides using FluoreGuard Mounting (Hard Set, ScyTek Laboratories 
Inc., Logan, UT, USA) before examination using a DMLB fluorescence microscope (Leica 
Microsystems, Wetzlar, Germany). Briefly, the number of nuclei per high-power field was counted in 
ten microscopic fields at 1000-fold magnification on oil immersion with a 100x objective (PL FLUOTAR 
100x/1.30, OIL, ∞/0.17/D, Leica Microsystems) and a 10x ocular objective (Leica L-Plan 10x/25M, 
Leica Microsystem) followed by determination of the mean value. The mean number of nuclei per field 
of irradiated samples was then compared to control (non-irradiated) samples. 
 
2.8 Experimental design of infection 
2.8.1 Irradiation of infected HCjE at 40 hours post infection (hpi) 
HCjE were seeded on a 24-well plate, incubated for 48 h and infected with EBs at a multiplicity of 
infection (MOI) of 0.1 or 1. Briefly, EBs were diluted in 1 mL neutralization medium per sample and 
used to inoculate 100% confluent HCjE monolayers. Plates were then centrifuged for 1 hour at 1000 g 
and 25 °C. Afterwards, inocula were aspirated and replaced by 1 mL incubation medium without 
gentamycin for further incubation of plates at 37°C and 5% CO2. At 40 hpi, infected monolayers were 
irradiated with wIRA alone or wIRA/VIS, as described in 2.6, and incubated for 3 h before they were 
fixed in methanol for immunofluorescence or collected for titration by sub-passage as previously 
described (20) (Figure 2A). Non-irradiated cultures were used as controls. 
 
2.8.2 Irradiation of EBs and HCjE prior to infection  
For this experiment, HCjE were seeded and incubated for 48 h. During incubation, cell monolayers 
were irradiated four times 8 h, 6 h, 3 h and immediately before infection with EBs, which had been 
exposed to irradiation by transferring 1 mL of EB-containing medium to a cell-free 24-well plate for 
treatment as previously established (20,21). Irradiation was performed with either wIRA alone or 
wIRA/VIS for 30 min as shown in 2.6.  
In total, there were four conditions: i) non-irradiated cells with non-irradiated EBs (control, E-C-), ii) 
irradiated cells with non-irradiated EBs (E-C+), iii) non-irradiated cells with irradiated EBs (E+C-) and 
iv) irradiated cells with irradiated EBs (E+C+). After infection with EBs, plates were incubated for 43 h 
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at 5% CO2 (37°C) and were then either fixed and stained for immunofluorescence microscopy or 
collected for reinfection as described in 2.9. (Figure 2B). 
 
 
 
Figure 2. Study design of the eye infection model.  
Human conjunctival epithelial cells (HCjE) were seeded and incubated for 48 h prior to infection with 
EBs (C. trachomatis serotype B) at a multiplicity of infection (MOI) 0.1 or 1. After centrifugation at 1000 
g for 1 h (25 °C), infected cultures were incubated and samples were collected for titration by sub-
passage at 43 h post infection (hpi). Time of irradiation treatment (prior or post infection) depended on 
the experiment. Irradiation was performed either with wIRA alone (2000 W/m2, RG 780 filter) or wIRA 
in combination with visible light (2100 W/m2, BTE 595) for 30 min per treatment. (A) Infected cell 
cultures were irradiated at 40 hpi (red arrow). (B) Cells were irradiated four times (8 h, 6 h, 3 h, 0 h) 
before they were infected with EBs, which had been irradiated or not immediately prior to infection (red 
arrows with dashed lines).  
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2.9 Immunofluorescence staining and microscopy 
Prior to immunofluorescence staining, cultures were fixed in methanol at 40 hpi or 43 hpi. Indirect 
immunofluorescence assays (IFA) were performed with a primary Chlamydiaceae family-specific 
mouse monoclonal antibody (1:200, LPS, Clone ACI-P, Progen, Heidelberg, Germany), detecting the 
chlamydial lipopolysaccharide and a secondary Alexa Fluor 488-goat anti-mouse antibody (1:500, 
Molecular Probes, Eugene, OR, USA), as previously described (20). DNA was stained with DAPI 
(1:1000, 1  µg/mL). After immunolabeling, coverslips were fixed onto glass slides and examined with a 
DMLB fluorescence microscope as described in 2.7.2. Samples from the original infection were 
screened at 1000-fold magnification on oil immersion, counting the number of nuclei and chlamydial 
inclusions in ten fields to determine the infection rate, whereas the number of inclusions per field was 
determined in 30 fields per coverslip for reinfection experiments at 200-fold magnification using a 20x 
objective (PL FLUOTAR 20x/0.50 PH2, ∞/0.17/B) and a 10x ocular objective (Leica L-Plan 10x/25 M, 
Leica Microsystems) as previously described (21). 
 
2.10 Titration by sub-passage / Reinfection experiments 
Samples for titration by sub-passage were collected at 43 hpi by scraping the cell monolayer into the 
medium. The samples were then stored at -80°C. After thawing, infected cells were sonicated for 5 
min with a sonicator (Brandson 250 Sonifier, Danbury, CT, USA) and used for titration by sub-passage 
in HeLa cells as previously described (20,33). 
Briefly, a serial dilution was performed on a 24-well plate seeded with HeLa cells before centrifugation 
for 1 hour at 1000 g and replacement of the inoculum with 1 mL of HeLa growth medium (without 
gentamycin) supplemented with 1 µg/mL cycloheximide (Sigma-Aldrich). At 40 hpi, cultures were fixed 
and immunolabeled as described in 2.9. For analysis, the number of inclusions at 200-fold 
magnification in 30 random microscopic fields were counted and the number of inclusion-forming units 
(IFU) in undiluted inoculum was determined and expressed as IFU per mL as previously described 
(32). 
 
2.11 Statistical analysis 
All statistical analyses were performed with the GraphPad Quickcalcs software 
(www.graphpad.com/quickcalcs) as previously described (21). If not stated otherwise, all results are 
presented as means ± standard deviation (SD) of the indicated number of experiments. The 
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significance of differences was estimated by unpaired t test for all cell culture experiments and a p-
value of <0.05 was considered significant. One-way ANOVA followed by Tukey-test for multiple 
groups was used for comparison of temperature increase in the pig eyes experiments and 
experiments with mouse retina explants after varying doses of wIRA. Unpaired two-tailed student’s t-
test was used for ELISA analysis. For all analyses a CI = 95% with *p < 0.05, **p < 0.01 and ***p < 
0.001 was defined as statistically significant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 18 
3. Results 
3.1 wIRA-induced temperature increase is not altered by the visible light component in intra-
well or cornea but is slightly elevated in the vitreous body.  
In a previous study, we showed that visible light (380-780 nm) significantly contributed to the increase 
of intra-well temperature at high doses of irradiation in in vitro cultured cells (21). Consequently, we 
investigated whether this significant rise in intra-well temperature also occurs at a visible light 
spectrum of 595 to 780 nm, and how the temperature curve compares to those generated in ex vivo 
models. Briefly, we evaluated the temperature curve both within the wells of a 24-well plate of cultured 
cells and in ex vivo in pig eyes during irradiation with wIRA alone or with wIRA/VIS for 30 min. For the 
in vitro infection model, HCjE cells were seeded on coverslips in 24-well plates and the intra-well 
temperature was measured at the bottom of the wells every 5 min. For wIRA alone, the starting 
temperature was 35.41 °C (± 0.25 °C) followed by a rapid increase to 37.23 °C (± 0.2 °C) within 5 min 
before reaching a plateau of approximately 37.7 °C after 10 min of irradiation. The temperature curve 
of wIRA/VIS looked similar to that of wIRA alone, though the starting temperature was slightly lower 
with 34.39 °C (± 0.73 °C, Figure 3A, left panel). After 30 min of irradiation, the final intra-well 
temperature was 37.71 °C (± 0.12 °C), which was not significantly different from wIRA/VIS irradiation 
(37.54 ± 0.07 °C, Figure 3A, right panel).  
The vitreal temperature of perfused pig eyes was adjusted to the physiological temperature of 34° C 
(34). WIRA/VIS was then applied for 30 min, which led to a rapid increase in temperature within the 
first 10 min of treatment before reaching a plateau similar to that of irradiated HCjE in a 24-well plate 
(Figure 3B, left panel). Interestingly, we found that the final vitreal temperature was significantly lower 
following wIRA/VIS irradiation (37.64 °C ± 0.34 °C) compared to wIRA alone (38.4 ± 0.73 °C, Figure 
3B, right panel). In contrast to irradiation of HCjE and the vitreous body, where the mean temperature 
increased up to 38 °C in the course of 30 min and a plateau was reached within the first 5-10 min, 
average surface temperature of the cornea did not exceed 35 °C. Initial corneal temperature started at 
33.63 °C (± 0.15 °C) and 33.66 °C (± 0.06 °C) and rose to 34.9 °C (± 0.62 °C) and 34.5 °C (± 0.61 °C) 
after 30 min for wIRA alone and wIRA/VIS, respectively (Figure 3C, left panel). Similar to irradiation of 
HCjE, the temperature differences between the two irradiation spectra groups were not significant 
(Figure 3C, right panel). 
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Figure 3. The visible light component (595-780 nm) does not significantly increase intra-well, 
vitreal or corneal temperature. 
(A) Monolayers of HCjE seeded on a 24-well plate were irradiated for 30 min with either wIRA alone 
(RG 780 filter, 2000 W/m2) or wIRA and visible light (BTE 595, 2100 W/m2). The mean intra-well 
temperature of three wells per condition was evaluated every 5 min in three independent experiments. 
Shown is the temperature profile for each condition in the course of irradiation (left panel) and the 
mean intra-well temperature after 30 min of irradiation (right panel; mean ± SD; n.s. not significant; t 
test). Additionally, perfused pig eyes were irradiated similarly after adjusting (B) the vitreal or (C) the 
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corneal temperature to 34°C whereupon the temperature was measured constantly (mean ± SD; n=3 
for wIRA alone; n=5 for wIRA/VIS, * p < 0.05; one way ANOVA). 
 
3.2 WIRA/VIS increases vitreal and corneal temperature of constantly perfused pig eyes in a 
dose dependent manner. 
As determined in our previous experiment, wIRA/VIS and wIRA treatments result in similar 
temperature curves, despite varying vitreal temperature, after 30 min. Therefore, in order to further 
investigate the influence of the irradiation dose in an ex vivo model, we irradiated perfused pig eyes 
with wIRA/VIS for 30 min at 1000, 2100, 3700 and 5000 W/m2. As expected, we found a positive 
correlation between temperature increase and irradiation dose, with each dose significantly varying 
from the other. For example, the vitreal temperature was significantly increased during irradiation at 
1000 W/m2 (p = 0.0025), and final vitreal temperature was 35.8 °C ± 0.4 °C after 30 min in contrast to 
a final temperature of 41.3 °C (± 0.7 °C) following treatment at 5000 W/m2 (Figure 4A). 
In opposition to the vitreous body results, continuous temperature measurement of the constantly 
perfused corneal surface resulted in a different irradiation dose response. Neither 1000 W/m2 nor 
2100 W/m2 of wIRA/VIS induced a significant increase against the physiological start temperature of 
34 °C (34–36) (Figure 4B). However, higher doses led to a significant temperature increase after 30 
min at 3700 W/m2 and 5000 W/m2 with 38.6 °C ± 1.13 °C and 41.13 °C ± 0.93° C observed 
respectively.   
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Figure 4. wIRA/VIS increases vitreal and corneal temperature of constantly perfused pig eyes 
in a dose dependent manner.  
Perfused pig eyes were irradiated with wIRA and visible light (BTE 595) at varying irradiation doses for 
30 min after initial adjustment of the vitreal or corneal temperature to 34 °C. The temperature (A) 
within the vitreous body and (B) on the cornea was continuously measured during irradiation (mean ± 
SD; n=3; n.s. not significant, * p < 0.05, ** p < 0.01; one way ANOVA). 
 
3.3 Retina explants of adult and postnatal mice withstand temperature exposure up to 40°C 
Irradiation of perfused pig eyes revealed a strong dose-dependent increase in vitreal temperature. 
Since an increase of temperature within the vitreous body may be associated with elevated 
temperature of the neighboring retinal tissue, we further analyzed the impact of hyperthermia on the 
expression levels of general molecular markers of cytotoxicity in the retina. Briefly, retinal explants of 
mice were exposed to 40 °C for 30 min in the presence or absence of wIRA/VIS at 1000 W/m2. 
Retinae of both adult and postnatal mice (10 days, P10) were used for the experiment since the latter 
corresponds with the retinal developmental stage of human neonates and infants. Measuring the 
levels of phosphorylated stress kinases p38, Akt, Erk 1/2 and SAPK/JNK by ELISA, we observed no 
significant changes immediately (0 h), 3 h or 24 h following treatment in retinae of adult mice (Figure 
5A). The only increase observed were the pSAPK/JNK levels by a factor of 1.9 immediately after both 
40 °C alone and in combination with irradiation in the retinae of postnatal mice (Figure 5B). At the later 
time points (3 h and 24 h), no changes in the level of stress kinases were observed in either adult or 
postnatal retinae (Figure 5).   
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Figure 5. Levels of general and molecular markers of cytotoxicity are unaffected by both 
hyperthermia alone or in combination with irradiation in adult and postnatal mouse retina 
except for a rapid increase of pSAPK/JNK in the postnatal retina.  
Retinal explants of (A) adult or (B) postnatal mice (P10) were irradiated with wIRA and visible light 
(BTE 595, 1000 W/m2) for 30 min. Temperature was adjusted to 37 or 40 °C during the irradiation 
process. Tissues were subsequently collected after 0 h, 3 h and 24 h at 37°C. Measurements for the 
levels of p-p38, pAkt, pErk1/2 and pSAPK/JNK by ELISA assay are shown. Values are normalized to 
the 37 °C control values (mean ± SD; n=3).  
 
3.4 Cell viability is not reduced following irradiation 
Determination of cell viability is an important in vitro parameter to detect potentially harmful effects of a 
treatment method. In a previous study, we showed that the viability of permanent cell lines (HeLa, 
Vero) was not negatively affected by wIRA/VIS even after long-term treatment for more than four 
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hours up to one day after exposure (20). In order to exclude possible damaging effects of wIRA and 
wIRA/VIS irradiation to the primary conjunctival cell line HCjE, we measured the cell viability post 
treatment using two different methods.  
First, cell metabolism was assessed with the AlamarBlue assay after single-dose or four times 
irradiation of HCjE by adding 10 % AlamarBlue immediately after the last treatment and processing 
the samples as described in 2.7.1. We found that irradiation of HCjE with wIRA alone led to a slight 
reduction in cell viability to 86.99% (± 3.96 %) and 78.54% (± 8.67 %) of the control value after single 
and four times irradiation, respectively, which was significant in both cases (p = 0.0432 after single, p 
= 0.0488 after four times irradiation, Figure 6A). However, wIRA/VIS did not significantly reduce the 
cell viability, with reductions to 95.37 % ± 0.65 % for single (p = 0.0525) and 88.13 % ± 6.38 % for four 
times irradiation versus control values (p = 0.0999, Figure 6B). 
Second, we calculated the mean number of cells per high-power field in order to identify possible cell 
loss due to treatment. There was no significant decrease in the average number of cells in irradiated 
HCjE compared to non-irradiated HCjE regardless of treatment. In detail, we found that wIRA alone 
and wIRA/VIS were associated with 21.67 cells/field ± 5.33 and 21.67 cells/field ± 2.04, respectively, 
compared to the non-irradiated control with 21.48 cells/field ± 2.69 following single-dose irradiation 
(Figure 6C). Similarly, after irradiating HCjE four times, the number of cells per field was 22.5 ± 0.78 
for wIRA/VIS and 21.73 ± 2.41 for wIRA alone. Non-irradiated cultures yielded 21.33 cells/field ± 1.21 
(Figure 6D).  
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Figure 6. Cell viability of HCjE post irradiation. 
(A-B) present the results of the AlamarBlue assay as mean ± SD (n ≥ 2; t test, * p > 0.05). Briefly, 10% 
AlamarBlue dye was added to the medium for three hours immediately after irradiating HCjE (A) once 
or (B) four times with either wIRA alone (RG 780 filter, 2000 W/m2) or wIRA and visible light (BTE 595, 
2100 W/m2) for 30 min per treatment. Heat-denatured samples (h.d.) were included as killing controls. 
For (C-D), the number of nuclei per field at 1000x magnification was evaluated in 10 fields per 
condition 43 hours post infection (hpi) with C. trachomatis serotype B. Shown is the mean number of 
nuclei following (C) single-dose irradiation 40 hpi, or (D) after irradiation 8 h, 6 h, 3 h and immediately 
prior infection (mean ± SD; n.s. not significant; n ≥ 3; t test). Non-infected and non-irradiated HCjE 
cultures were used as control. Each irradiation was applied for 30 min with either wIRA alone (RG 
780, 2000 W/m2) or wIRA and visible light (BTE 595, 2100 W/m2).   
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3.5 Chlamydial infectivity is reduced following single-dose irradiation of mature chlamydial 
infections in HCjE  
We have previously established that infections with the genital C. trachomatis serovar E strain or C. 
pecorum isolated from a swine abortion were significantly inhibited when wIRA/VIS (380-1400 nm) or 
wIRA alone (780-1400 nm) was applied 40 h post infection of HeLa or Vero cells, regardless of the 
infectious dose and the radiation spectrum (20,21). We wished to confirm these results by 
investigating the effects of wIRA alone or wIRA with a partial visible light spectrum (595-780 nm, BTE 
595) on mature chlamydial inclusions in HCjE. For this purpose, we infected monolayers with C. 
trachomatis B EBs, irradiated them at 40 hpi for 30 min, and collected samples three hours later for 
titration by sub-passage as described in 2.11. Cultures were infected with doses of MOI 0.1 (Figure 7) 
and MOI 1.0 (Figure S1A) and irradiated with wIRA/VIS or wIRA alone at 2100 W/m2 and 2000 W/m2, 
respectively. 
Surprisingly, we found that while wIRA alone reduced the infectivity of mature chlamydial inclusions by 
35.27 % (± 8.16 %) (Figure 7A), wIRA/VIS reduced it by 53.81 % ± 4.62 % at MOI 0.1 (Figure 7B). 
The difference between the two irradiation spectra was significant (p = 0.0298). In contrast, there was 
no significant difference between the two infectious doses (MOI 0.1, 1) following treatment with wIRA 
alone (p = 0.721, Figure S1A). 
 
 
 
Figure 7. Infectivity is reduced following single-dose irradiation of mature chlamydial 
infections in HCjE.  
HCjE were infected with C. trachomatis serotype B at MOI 0.1 and irradiated or not 40 hours post 
infection (hpi) for 30 min with (A) wIRA alone (RG 780, 2000 W/m2) or (B) wIRA and visible light (BTE 
595, 2100 W/m2). Cultures were collected at 43 hpi for titration by sub-passage. Inclusion-forming 
units per mL (IFU/mL) are shown as percent of non-irradiated controls (mean ± SD; * p < 0.05; n = 3; t 
test). 
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3.6 Irradiation of EBs and cells prior to infection enhances the anti-chlamydial effect 
In previous publications (20,21), we showed that irradiation of C. pecorum and C. trachomatis E EBs 
prior to infection of either Vero or HeLa cells led to reduced chlamydial infectivity. 
In this study, we wished to confirm these findings in an eye infection model by subjecting C. 
trachomatis B EBs to wIRA alone (2000 W/m2) and wIRA/VIS (2100 W/m2) for 30 min before infection 
of HCjE. In addition, we further investigated the effect of treating cells alone or in combination with EB 
treatment by irradiating cells 8 h, 6 h, 3 h and immediately prior to infection with irradiated or non-
irradiated EBs, which resulted in four conditions for both radiation spectra: a) non-irradiated cells 
infected with non-irradiated EBs (control, E-C-), b) irradiated cells infected with non-irradiated EBs (E-
C+), c) non-irradiated cells infected with irradiated EBs (E+C-) and d) irradiated cells infected with 
irradiated EBs (E+C+). 
We found that irradiating both EBs and cells led to the strongest decrease in infectivity compared to 
non-irradiated controls for both wIRA alone and wIRA/VIS, with decreases to 73.54 % ± 0.55 % 
(Figure 8A) and 86.85 % ± 0.92 % (Figure 8B) of the control, respectively. Next, irradiation of EBs 
alone led to a strong reduction in the infectivity of EBs, especially in the presence of a visible light 
component (wIRA alone: 45.73 % ± 7.80 %, wIRA/VIS: 30.54 % ± 2.96 % of non-irradiated controls). 
However, treatment of only HCjE prior to infection also led to a significant reduction in chlamydial 
infectivity post infection for both wIRA alone (35.37 % ± 1.53 %) and in combination with visible light 
(wIRA/VIS, 33.96% ± 1.54 %) versus controls. Interestingly, while the effect of irradiating cells with 
wIRA alone compared to wIRA/VIS was not significantly different (p = 0.3235), wIRA/VIS led to a 
significantly more efficient reduction compared to wIRA alone for both EB treatment (p = 0.0344) and 
the combination treatment of both EBs and cells (p < 0.0001). Similarly to treatment of mature 
chlamydial inclusions (3.5) and previous studies (21), there was no significant difference between the 
infectivity of EBs at MOI 1 (39.95 % ± 7.94 % to non-irradiated control) and MOI 0.1 (42.25 % ± 10.68 
%) after irradiation with wIRA alone (Figure S1B).  
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Figure 8. Irradiation of C. trachomatis B EBs and HCjE prior to infection enhances the anti-
chlamydial effect. 
HCjE were irradiated (C+) or not (C-) four times 8 h, 6 h, 3 h and immediately prior to infection with 
irradiated (E+) or non-irradiated (E-) C. trachomatis serotype B EBs. After 43 h of incubation, cultures 
were collected for titration by sub-passage. Shown is the mean ± SD (* p < 0.05; n ≥ 3; t test) of 
inclusion-forming units per mL (IFU/mL) as percent of a non-irradiated control (E-C-). Each irradiation 
treatment was performed for 30 min either with (A) wIRA alone (RG 780, 2000 W/m2) or (B) wIRA in 
combination with visible light (BTE 595, 2100 W/m2). 
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4. Discussion  
Blinding trachoma is still endemic in many parts of the world even though the WHO has been 
combating the disease since 1997 (1–4). To date, antibiotic treatment as part of the SAFE strategy 
has not produced the desired results, leaving a considerable number of people still infected despite 
therapy (4,5). This being the case, the aim of our study was to develop a possible new, non-chemical 
treatment method for trachoma patients using near-infrared A radiation. This approach was evaluated 
by using an in vitro infection cell culture model and two ex vivo eye models. 
Since the eye is one of the most photosensitive organs, careful examination of the eye during and 
after irradiation treatment is crucial to exclude any damage or unwanted side effects. It is known that 
wIRA has a thermal component (18,20,37), which prompted us to examine temperature during 30 min 
of irradiation with either wIRA or wIRA/VIS in perfused pig eyes. The initial temperature was set to 34 
°C to represent the physiological in vivo eye temperature. Temperature measurements within the eye 
are challenging and reports of ocular temperature in the literature show variable results. Salcedo-
Villanueva et al. determined a mean vitreous temperature in human eyes of 33.04 °C during cataract 
surgery (38), while Landers et al. found the mid-vitreous temperature to be between 33.2 and 34.7 °C 
(34). The temperature was similar in anaesthetized pigs, reporting a mean of 34.7-35.8 °C for the 
vitreous body and 34.3 °C for the aqueous chamber. Temperature near the retina was found to be 
slightly higher (34.4−35.3 °C) as it contains blood vessels and is consequently influenced by the body 
temperature (36).  
In our ex vivo model of perfused pig eyes, we found that the corneal temperature never exceeded 35  
°C at radiation doses of 2000 W/m2 wIRA and 2100 W/m2 wIRA/VIS. Since the vitreal temperature 
after irradiation with the dose of 2100 W/m2 was 37 °C, which equals the physiological body 
temperature, we chose this dose as a potential therapeutic radiation dose and used it in all further 
experiments. The temperature difference between irradiation with wIRA and irradiation with wIRA/VIS 
on the cornea was not significant. The only slight temperature elevation in our ex vivo model is a 
promising result regarding possible future administration in vivo. However, the actual in vivo 
temperature could be different, given the fact that the cornea is an avascular tissue. Thus corneal 
temperature depends on the temperature of the eye lids, while the lids are closing, and on the ambient 
temperature as well as the aqueous temperature when the eye is opened (39). 
Similar results were obtained in the cell culture experiments. Even though the initial intra-well 
temperature was slightly higher with wIRA alone, there was no significant difference amongst the 
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filters after the irradiation period of 30 min. In contrast to these findings, the final temperature inside 
the vitreous body was significantly higher following irradiation with wIRA alone compared to irradiation 
with wIRA/VIS. A possible explanation for this could be that the vitreous body was the only closed 
system in our experiments, thus accumulating heat energy, whereas cornea and wells were exposed 
to ambient temperature.  
Several studies have aimed to evaluate consequences of increased temperatures on ocular 
structures. Some authors claimed that hyperthermia induced by infrared radiation may lead to cataract 
formation (40,41), while Wolbarsht hypothesized that this process was not thermal but 
photochemically-induced (42). In a more recent publication, Yu et al. performed in vivo experiments 
with rats and found that exposure to 197    W/cm2 1090-nm infrared reflectrography (IRR) for eight 
seconds led to a temperature increase of 10 °C at the limbus and 26 °C near the retina, which induced 
cataract (43). However, Yu et al. used a laser as a source for IRR, which contains more heat radiation. 
In wIRA, part of the heat energy is filtered through the water cuvette (16), so heating of the tissue 
should be rather moderate. 
The retina belongs to the main structures of the eye, which converts electromagnetic radiation into 
neuronal signals (44). In order to exclude damage following wIRA treatment, we exposed retina 
explants of postnatal and adult mice to different temperatures of up to 40 °C with or without the 
combination of wIRA irradiation and measured the expression of general and molecular cytotoxicity 
markers. No changes regarding expression levels in adult retinae were observed, even in samples 
with temperature treatment of 40 °C in combination with wIRA. In retinal tissue of postnatal mice only 
the levels of pSAPK/JNK were increased directly after treatment with temperature alone and in 
combination with wIRA. These results suggest that even in a highly vulnerable model, there is no 
significant increase in the level of observed stress markers of the retina after wIRA application or 
temperature exposure up to 40 °C. Iwami et al. recently described a laser-induced temperature of 50-
52 °C to be the threshold for retinal pigment epithelium (RPE) cell death. Moreover, they observed that 
sub-lethal temperatures of about 43 °C increase cell defense mechanisms against oxidative stress 
(45). These mechanisms can be induced by hyperthermia (46). Though, as mentioned before, these 
temperatures of lethal hyperthermia are not expected during wIRA exposure (16). 
Cell viability following wIRA irradiation was further examined in vitro. Previously, we demonstrated that 
wIRA/VIS does not reduce cell metabolism of HeLa or Vero cells, nor were there any signs of 
cytotoxicity in HeLa cells (20). In our recent experiments, metabolism of the conjunctival cell line HCjE 
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was only slightly reduced using the highest achievable dose of wIRA without visible light. However, 
irradiation with wIRA/VIS did not result in any considerable decrease of metabolic activity compared to 
the non-irradiated controls after single or four times irradiation for 30 min. We hypothesized that since 
HCjE is a healthy cell line, they are probably more susceptible to stressors than cell lines from a 
cancerous origin such as HeLa, possibly explaining the slight viability decrease after irradiation with 
wIRA alone. A recent study supports our findings, stating that metabolic activity was even enhanced 
after wIRA irradiation in another continuous cell line (47). Knels et al. irradiated Swiss albino mouse 
embryonic fibroblast cell-line NIH/3T3 cultures with 300 W/m2 (wIRA, 780-1400 nm) for either 60 or 
120 min demonstrating that the overall metabolic rate was increased post irradiation. Furthermore, it 
was significantly higher in all samples at 40 °C regardless of wIRA treatment compared to samples at 
37 °C. However, the authors state that cells under temperature exposure of 40 °C in combination with 
glyoxal showed a decreased metabolic activity, even after irradiation (47).  
Furthermore we could not detect any cell loss in HCjE monolayers irradiated either with wIRA or 
wIRA/VIS by enumerating nuclei per microscopic field as another indicator for potential cytotoxic 
effects. 
Based on our previous studies with C. pecorum in Vero cells and C. trachomatis E in HeLa cells, we 
established a trachoma infection model using the ocular strain C. trachomatis B in HCjE cells and 
irradiated samples at 40 hours post infection. The reduction of chlamydial infectivity was significant 
with both filters and similar to the results of previous experiments (20,21). The reduced infectivity 
following treatment with wIRA alone was not influenced by the chlamydial infection dose (MOI 0.1, 1). 
Interestingly, in cultures infected with only MOI 0.1, irradiation with wIRA/VIS decreased the 
chlamydial infectivity more efficiently than wIRA alone. However, in our previous study with cancerous 
cell lines (21), we did not see any additional reducing effect of VIS on mature chlamydial inclusions, 
hence this outcome could again be dependent on the characteristics of the non-cancerous cell line. 
The impact of VIS was further analyzed in another experiment, in which we irradiated EBs and HCjE 
prior to infection. Here we demonstrated that the relative decrease in chlamydial infectivity was 
significantly higher following treatment of EBs with wIRA/VIS compared to wIRA alone, which is in 
accordance with our previous findings (21). In addition, the visible light component had no significant 
influence on the chlamydial infectivity if only cells were irradiated prior infection leading to the 
conclusion that extracellular C. trachomatis B EBs are sensitive to visible light. 
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Furthermore we found that, independent of the visible light component, the highest decrease of 
chlamydial infectivity occurred if both EBs and cells were irradiated prior infection. Surprisingly, the 
number of chlamydial inclusions was also reduced following irradiation of uninfected HCjE alone 
without any direct treatment of Chlamydia leading us to hypothesize that a wIRA-induced cellular 
protective effect is stimulated against subsequent chlamydial infection. According to several other 
studies, this might be due to an increased cell metabolism (16–19). Knels et al. recently discovered 
that wIRA irradiation of fibroblast cultures not only enhances metabolic activity, but also that it has a 
protective effect on cells, improving their viability under oxidative stress. The authors consider a 
possible beneficial effect on mitochondria (47).  
In summary, we demonstrate that irradiation with wIRA/VIS or wIRA alone reduces chlamydial 
infectivity in primary human conjunctival epithelial cells infected with the trachoma strain C. 
trachomatis B at doses not reducing the cell viability.  
The required wIRA doses, which trigger this effect, cause only physiological temperatures on the 
cornea and in the vitreous body of perfused pig eyes. However, since these structures directly 
neighbor the retina, we further analyzed possible effects of hyperthermia on this neuronal tissue. 
Since hyperthermia has been shown to influence the activation of the mitogen-activated kinase 
(MAPK) and also the Akt pathway in parts of the brain (48), we elucidated the phosphorylation levels 
of p38 MAPK, Erk, JNK and Akt in the retina of adult and postnatal mice after 30 min of 40°C. Except 
for the postnatal retina, we failed to detect significant changes in the activation of these stress related 
pathways, which indicates a lack of degenerative stimuli after this treatment, at least in the adult 
situation.  
In particular, our results show that the addition of VIS contributes to the antimicrobial effect of this non-
chemical method. EBs appear to be highly sensitive to exposure to the visible light component 
specifically. There was also a greater reduction in the infectivity of mature chlamydial inclusions 
following exposure to wIRA/VIS compared to wIRA alone. Interestingly, the temperature increase in 
the vitreous body of pig eyes following wIRA/VIS exposure was less pronounced compared to 
irradiation with wIRA alone, leading us to conclude that, in addition to an already described irradiation 
dose effect, the radiation spectrum (780-1400 nm, 595-1400 nm) may additionally influence the effect 
of irradiation on chlamydial infection and tissue. 
We failed to observe wIRA-induced damage of HCjE or retinal tissue. Instead, we discovered a 
possible beneficial cellular effect, suggesting that near-infrared radiation with or without visible light 
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triggers cell mechanisms that protect the cell from chlamydial infections. Our study is the first of its 
kind demonstrating that near-infrared A radiation reduces chlamydial infections in primary human 
conjunctival epithelial cells in vitro without corresponding negative consequences in ex vivo models, 
providing the basis to introduce irradiation as a potential non-chemical method to treat trachoma.  
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Supporting information 
 
 
 
Figure S1.  
The effect of wIRA alone (RG 780, 2000 W/m2) on (A) C. trachomatis serotype B-infected cultures at 
40 hours post infection and (B) EBs at MOI 1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
